We found that, in iFLs induced by the reprogramming treatment of ROCK–mTOR inhibitors, expressions of a set of fat differentiation factors were increased by greater than tenfold (Fig. 3c), suggesting that these factors may be involved in breast cancer fat cell conversion. Here, MTOR is linked to breast carcinoma.